These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 33383667

  • 1. New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models.
    Chai AB, Hartz AMS, Gao X, Yang A, Callaghan R, Gelissen IC.
    Int J Mol Sci; 2020 Dec 29; 22(1):. PubMed ID: 33383667
    [Abstract] [Full Text] [Related]

  • 2. P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?
    Chai AB, Leung GKF, Callaghan R, Gelissen IC.
    FEBS J; 2020 Feb 29; 287(4):612-625. PubMed ID: 31750987
    [Abstract] [Full Text] [Related]

  • 3. Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model.
    Vulin M, Zhong Y, Maloney BJ, Bauer B, Hartz AMS.
    Fluids Barriers CNS; 2023 Oct 06; 20(1):70. PubMed ID: 37803468
    [Abstract] [Full Text] [Related]

  • 4. MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.
    Kuhnke D, Jedlitschky G, Grube M, Krohn M, Jucker M, Mosyagin I, Cascorbi I, Walker LC, Kroemer HK, Warzok RW, Vogelgesang S.
    Brain Pathol; 2007 Oct 06; 17(4):347-53. PubMed ID: 17610523
    [Abstract] [Full Text] [Related]

  • 5. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S, Brenn A, Grube M, Niedrig K, Holtfreter S, von Bohlen und Halbach O, Groschup M, Keller M, Vogelgesang S.
    Curr Alzheimer Res; 2017 Oct 06; 14(6):656-667. PubMed ID: 27915995
    [Abstract] [Full Text] [Related]

  • 6. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
    Storck SE, Hartz AMS, Bernard J, Wolf A, Kachlmeier A, Mahringer A, Weggen S, Pahnke J, Pietrzik CU.
    Brain Behav Immun; 2018 Oct 06; 73():21-33. PubMed ID: 30041013
    [Abstract] [Full Text] [Related]

  • 7. Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model.
    Ding Y, Zhong Y, Baldeshwiler A, Abner EL, Bauer B, Hartz AMS.
    Fluids Barriers CNS; 2021 Mar 06; 18(1):10. PubMed ID: 33676539
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway.
    Hartz AM, Zhong Y, Wolf A, LeVine H, Miller DS, Bauer B.
    J Neurosci; 2016 Feb 10; 36(6):1930-41. PubMed ID: 26865616
    [Abstract] [Full Text] [Related]

  • 10. Evidence against a role of P-glycoprotein in the clearance of the Alzheimer's disease Aβ1-42 peptides.
    Bello I, Salerno M.
    Cell Stress Chaperones; 2015 May 10; 20(3):421-30. PubMed ID: 25591827
    [Abstract] [Full Text] [Related]

  • 11. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
    Abdallah IM, Al-Shami KM, Yang E, Kaddoumi A.
    Int J Mol Sci; 2021 Jan 27; 22(3):. PubMed ID: 33513818
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium.
    Wang Z, Sharda N, Omtri RS, Li L, Kandimalla KK.
    Mol Pharmacol; 2023 Nov 27; 104(5):203-213. PubMed ID: 37541759
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
    Qosa H, Abuasal BS, Romero IA, Weksler B, Couraud PO, Keller JN, Kaddoumi A.
    Neuropharmacology; 2014 Apr 27; 79():668-78. PubMed ID: 24467845
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.
    Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W, Kunert-Keil C, Walker LC, Warzok RW.
    Pharmacogenetics; 2002 Oct 27; 12(7):535-41. PubMed ID: 12360104
    [Abstract] [Full Text] [Related]

  • 18. Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells.
    Shubbar MH, Penny JI.
    Biochim Biophys Acta Gen Subj; 2018 Oct 27; 1862(10):2314-2322. PubMed ID: 30048740
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.